YAP-dependent proliferation by a small molecule targeting annexin A2

March 15th, 2021 by Sophia Z. Shalhout

Nature Chemical Biology, Published online: 15 March 2021; doi:10.1038/s41589-021-00755-0

Annexin A2 (ANXA2) is identified as the target of a pharmacological YAP activator and as a druggable component of the Hippo pathway.